Critical insight at the speed of light.
Avalyra is…
Avalyra is a next-generation MedTech company advancing a new standard of care through biophotonics—the use of light to non-invasively monitor what’s happening inside the human body. Our platform delivers critical insight when it matters most, transforming how critical care decisions are made—with real-time insight, powered by light.
We’re building a technology platform to deliver non-invasive, high-fidelity monitoring of internal physiological changes with speed, precision, and simplicity. Our mission: to give clinicians and care teams the clarity they need—when it matters most.
Avalyra is currently focused on high-risk dialysis, trauma, and maternal health settings where time-sensitive, life-saving decisions are made every day.
Proprietary, AI-Augmented Intelligence
Breakthrough Biophotonic Technology
Non-invasive, Real-Time Bioanalytics
Avalyra does…
Avalyra’s health technology platform combines advanced optical sensing, intelligent signal processing, and cloud-enabled dashboards to track internal fluid dynamics in real time—without the need for invasive lines, blood draws, or bulky machines.
Our initial focus for clinical applications include:
Hemorrhage detection in trauma and obstetrics
Fluid status monitoring in dialysis
Remote decision support for care teams across clinical and austere environments
Critical insight at the speed of light.
Our Technology Platform
At the core of Avalyra’s technology is a photonics-driven sensor system designed to detect subtle changes in vascular volume, plasma levels, and hematocrit with unprecedented sensitivity. Built for speed, scale, and integration, the platform is hardware-agnostic and designed to evolve with clinical needs—from outpatient dialysis to battlefield trauma care.
Avalyra is on path to finalize exclusive rights to the foundational technology underpinning this platform and anticipates full IP assignment in 2025. Development has been supported by prior SBIR funding and human data validation.
Use Cases in Development
A MedTech Platform Being Built for Critical Care Settings and Management of Chronic Conditions
Avalyra’s platform is being designed to support multiple high-impact clinical applications:
Dialysis Optimization & Management
Preparing to usher in a new standard of care in dialysis management; enabling personalized fluid management and reducing cardiovascular complications.
Maternal Hemorrhage Detection
On path to address a leading cause of maternal mortality with wireless, real-time postpartum monitoring - wherever birth happens.
Trauma & Defense
Early internal hemorrhage detection for battlefield triage, en route care, and remote deployments - empowering faster, smarter interventions.
Our Approach to Technology Development
Avalyra is building for scale and speed with a capital-efficient, license-first strategy.
Our current status includes:
A clinically validated device platform
IRB-Approved Clinical Trials for Dialysis, and Internal Hemorrhage
DoD SBIR-Backed Tech with Phase III Path
SAM.gov registered and qualified Federal Contractor